期刊文献+

uNTX、sICTP及sBALP表达在恶性肿瘤骨转移中的临床意义 被引量:5

The Clinical Significance of Measurement of Urine NTX,Serum ICTP and BALP in Patients with Bone Metastasis from Malignant Tumors
下载PDF
导出
摘要 目的探讨尿Ⅰ型胶原交联氨基末端肽(uNTX)、血清Ⅰ型胶原羧基末端肽(sICTP)及骨碱性磷酸酶(sBALP)表达在恶性肿瘤骨转移患者中的临床意义。方法对32例恶性肿瘤骨转移患者,在治疗前后分别采用酶联免疫吸附法(ELISA)、小麦菌凝集素沉淀法,测定uNTX、sICTP及sBALP水平。随访骨相关事件(SREs)及生存状况。结果患者基线uNTX/Cr、sICTP及sBALP水平明显高于正常,其浓度与骨转移负荷呈正相关性,与疼痛强度无显著相关性。治疗3个月时uNTX/Cr、sICTP及sBALP水平明显降低,而放射性核素全身骨显像(ECT)尚无明显改变;32例患者中24例基线uNTX/Cr水平高于正常水平,治疗后降至正常水平的15例患者骨相关事件发生率为53%,而治疗后仍维持在较高水平的9例患者为89%(P=0.039);32例患者中27例基线sICTP水平高于正常,治疗后16例降至正常,11例仍维持在较高水平,两者骨相关事件发生率为50%和91%(P=0.032);26例基线sBALP水平高于正常值,治疗后16例降至正常水平,10例仍维持在较高水平,两者骨相关事件发生率为50%和90%(P=0.038)。uNTX/Cr、sICTP及sBALP水平与肿瘤患者生存率无明显相关性。结论骨代谢标记物uNTX、sICTP及sBALP对恶性肿瘤骨转移的诊断、疗效的监测及骨相关事件的预测具有一定的价值。 Objective To study the value of measurement of urine amino-terminal telopeptide of typeⅠcollagen(uNTX),serum Pyridinoline crosslinked C-telopeptides of Type I collagen(sICTP)and bone spesific alkaline phosphatase(sBALP)in patients with bone metastasis from solid tumors.Methods 32 patients with bone metastasis from malignant tumor were recruited.UNTX,sICTP and sBALP were measured before and during the chemotherapy.UNTX and sICTP was measured by ELISA assays.Serum BALP was measured by precipitation with wheat germ lectin.Skeletal-related events(SREs)were recorded during the follow-up and survival were calculated.Results The concentration of uNTX,sICTP and sBALP in patients with bone metastases was higher than the upper limit of normal range.A positive correlation was observed between the markers value and the extent of bone metastases.At the third month,the concentrations of uNTX,sICTP and SBALP were significantly decreased,but radionuclide whole-body bone imaging had no change.Of the 32 patients,24 had initially elevated uNTX values.After treatment 15 of the 24 patients finished with normal uNTX values,while 9 of the 24 patients had their uNTX values remained abnormally elevated.The proportions of patients with SREs in these two subgroups were 53% and 89%(P=0.039).Of the 32 patients,27 had initially elevated sICTP values.After treatment 16 of the 27 patients finished with normal sICTP values,while 11 of the 27 patients had their sICTP values remained abnormally elevated.The proportions of patients with SREs in these two subgroups were 50% and 91%(P=0.032).Of the 32 patients,26 had initially elevated sBALP values.After treatment 16 of the 26 patients finished with normal sBALP values,while 10 of the 26 patients had their sBALP values remained abnormally elevated.The proportions of patients with SREs in these two subgroups were 50% and 90%(P=0.038).The level of uNTX/Cr,sICTPand sBALP was not correlated with survival.Conclusion Urinary NTX,serum ICTP,BALP may be useful in the diagnosis,prognosis and prediction of SREs of patients with bone metastasis from malignant tumors.
出处 《实用癌症杂志》 2010年第3期258-262,共5页 The Practical Journal of Cancer
关键词 骨转移 Ⅰ型胶原氨基末端肽 Ⅰ型胶原羧基末端肽 骨碱性磷酸酶 Kskeletal metastasis Amino-terminal telopeptide of typeⅠcollagen Pyridinoline crosslinked C-telopeptides of Type I collagen Bone-specific alkaline phosphatase
  • 相关文献

参考文献11

  • 1Hanson DA,Eyre DR.Molecular site specificity of pyridinoline and pyrrole cross-linds in type I collagen of human bone[J].J Biol Chem,1996,271(43):26508.
  • 2Rybak LD,Rosenthal DI.Radiological imaging for the diagnosis of bone metastases[J].Q J Nucl Med,2001,45(3):53.
  • 3Peterson JJ,Ktansdorf MJ,O Connor MI.Diagnosis of occult bone metastases:positron emission tomography[J].Clin Ort hop,2003,415(10):120.
  • 4Cook GJ,Houston S,Rubens R,et al.Detection of bone metastases in breast cancer by 182FDG PET:Differing metabolic activity in osterblastic and osteolyic lesions[J].J Clin Oncol,1998,16(10):3375.
  • 5T Barreto A,Daenen F.Fluorine-18 deoxyglucosepositron emission tomography for the detection of bone metastases in patients with non small cell lung cancer[J].Eur J Nucl Med,1998,25 (9):1244.
  • 6J D Clemens,M V Herrick,F R Singer,et al.Evidence that serum NTX (collagen-type I N-telopeptides) can act as an immunochemical marker of bone resorption[J].Clin Chem,1997,43(11):2058.
  • 7L M Demers,M Kleerkoper.Recent advances in biochemical markers of bone turnover[J].Clin Chem,1994,40(11):1994.
  • 8Coleman R,Major P,Lipton A,et al.Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid[J].J Clin Oncol,2005,23(22):4925.
  • 9吕晓芳,于世英,冷彦.骨代谢生化指标在恶性肿瘤骨转移诊断中的价值[J].中国肿瘤临床,2007,34(3):154-156. 被引量:12
  • 10Piedra C,Erredaborde N,Traba M.Bone remodeling markers in detetion of bone metastases in prostate cancer[J].Clin Chim ACTA,2003,331:45.

二级参考文献10

  • 1余靖,邸立军,宛凤玲,勇威本.骨代谢生化指标诊断恶性肿瘤骨转移的临床意义[J].中国肿瘤临床,2005,32(20):1193-1196. 被引量:10
  • 2Hamaoka T, Madewell JE, Podoloff DA, et al. Bone imaging in metastatic breast cancer[J].J Clin Oncol, 2004, 22(14): 2942-2953
  • 3Demers LM, Costa L, Lipton A, et al. Biochemical markers and skeletal metastases [J]. Clin Orthop Relat Res, 2003, 415(Suppl):S138-S147
  • 4Coleman RE. The clinical use of bone resorption markers in patients with malignant bone disease [J]. Cancer, 2002, 94 (10):2521-2533
  • 5Kiuchi K, Ishikawa T, Hamaguchi Y, et al. Cross-linked collagen C- and N-telopeptides for an early diagnosis of bone metastasis from breast cancer[J]. Oncol Rep, 2002, 9(3): 595-598
  • 6Izumi M, Nakanishi Y, Takayama K, et al. Diagnostic value of bone-turnover metabolites in the diagnosis of bone metastases in patients with lung carcinoma[J]. Cancer, 2001, 91(8): 1487-1493
  • 7Horiguchi T, Tachikawa S, Kondo R, et al.Usefulness of serum carboxy-terminal telopeptide of type Ⅰ collagen (ICTP) as a marker of bone metastasis from lung cancer [J]. Jpn J Clin Oncol,2000, 30(4): 174-179
  • 8de la Piedra C, Castro-Errecaborde NA, Traba ML, et al. Bone remodeling markers in the detection of bone metastases in prostate cancer[J]. Clin China Acta, 2003, 331(1-2): 45-53
  • 9Brown JE, Cook RJ, Major P, et al. Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer,and other solid tumors[J].J Natl Cancer Inst, 2005, 7(1): 59-69
  • 10邸立军,刘淑俊,宛凤玲,朱步东,聂军.尿吡啶酚和脱氧吡啶酚在恶性肿瘤骨转移中的临床意义[J].中国肿瘤临床,2000,27(7):521-523. 被引量:8

共引文献11

同被引文献32

  • 1傅正,卢奕,姚智.OPG RANKL和RANK在肿瘤骨转移中的作用[J].中国肿瘤临床,2004,31(22):1316-1318. 被引量:7
  • 2钟英,杜明华,张矫,吴巍.ICTP、IGF-Ⅰ、BGP指标评价肝癌的研究[J].放射免疫学杂志,2006,19(2):95-97. 被引量:1
  • 3章火祥,于小妹,钭春凤,王丽君.ICTP、OC在乳腺癌骨转移中的应用[J].江西医学检验,2006,24(5):419-420. 被引量:3
  • 4吕晓芳,于世英,冷彦.骨代谢生化指标在恶性肿瘤骨转移诊断中的价值[J].中国肿瘤临床,2007,34(3):154-156. 被引量:12
  • 5Hanson D A, Eyre D R. Molecular site specificity of pyridin- oline and pyrrole cross-linds in type I collagen of human bone [ J ] Biol Chem, 1996,276 (43) : 26508.
  • 6于世英,王杰军,江泽飞.恶性肿瘤骨转移飞诊断与治疗[M].北京:中国协和医科大学出版社,2006:4-23.
  • 7Kingsley LA, Fourier PG, Chirgwin JM, et al. Molecular biol- ogy of bone metastasis [ J . Mol Cancer Ther,2007,6 ( 10 ) : 2609.
  • 8胡晓晔,邹青峰,金川,等.尿1型胶原交联氨基末端肽、血清骨源性碱性磷酸酶检测在实体瘤骨转移中的临床意义[J].实用肿瘤学杂志,2010,26(14):258.
  • 9S M Ali, L M Demers, K Leitzel, et al. Baseline serum NTx levels are prognostic in metastatic breast cancer patients with bone-only metastasis [ J ] Ann Oncol, 2006,15 (4) :455.
  • 10R E Coleman, P Major, A Lipton, et al. Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledron- ic acid [ J ]Clin Oncol,2005,23 (5):4925.

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部